Universidad Nacional Autonoma de Honduras, Tegucigalpa, Honduras.
National Institute for Cardio Pulmonary Diseases, National Autonomous University of Honduras, Tegucigalpa, Honduras.
Am Soc Clin Oncol Educ Book. 2021 Mar;41:199-220. doi: 10.1200/EDBK_320037.
Accurate pathologic evaluation is essential for proper diagnosis and treatment of patients with cancer. ASCO and the College of American Pathologists have successfully collaborated over the last 15 years to improve collaboration between clinical oncologists and pathologists and to standardize pathologic assay techniques. Cancer is an increasingly recognized societal burden in low- and middle-income countries. In 2015, ASCO and the College of American Pathologists implemented an initiative to identify countries that could benefit from peer insights by jointly convening an international workshop among members of both organizations and pathologists and clinical oncologists from Haiti, Honduras, Vietnam, and Uganda. Honduras was chosen as a pilot site, and representatives of ASCO, the College of American Pathologists, and the Honduras pathology and clinical oncology communities have identified areas in which collaboration might be productive. Multiple barriers, including high poverty levels, poor cancer awareness educational programs, lack of human resources, and delayed diagnosis and treatment, have resulted in a higher cancer mortality rate in Honduras compared with high/moderate-income countries and are shared by other low-income countries. ASCO and the College of American Pathologists member faculty supported a symposium led by Honduras colleagues for interested Honduran pathologists and oncologists. The Honduran communities are now working to establish national resource-appropriate guidelines for both pathology and clinical oncology. Taken together, these efforts indicate that barriers to meet the needs of the clinical oncologists in a low-income country such as Honduras are challenging but not insurmountable.
准确的病理评估对于癌症患者的正确诊断和治疗至关重要。美国临床肿瘤学会（ASCO）和美国病理学家协会（College of American Pathologists）在过去 15 年中成功合作，旨在加强临床肿瘤学家和病理学家之间的协作，并规范病理检测技术。癌症是低收入和中等收入国家日益严重的社会负担。2015 年，ASCO 和美国病理学家协会实施了一项倡议，旨在通过联合召集来自海地、洪都拉斯、越南和乌干达的组织成员、病理学家和临床肿瘤学家的国际研讨会，确定哪些国家可以从同行的专业知识中受益。洪都拉斯被选为试点国家，ASCO、美国病理学家协会以及洪都拉斯病理和临床肿瘤学领域的代表已经确定了可能具有协作潜力的领域。多种障碍，包括高贫困率、癌症意识教育项目不足、人力资源匮乏、诊断和治疗延误等，导致洪都拉斯的癌症死亡率高于高/中收入国家，且其他低收入国家也存在这些问题。ASCO 和美国病理学家协会的成员教师支持了由洪都拉斯同事为有兴趣的洪都拉斯病理学家和肿瘤学家举办的研讨会。洪都拉斯社区目前正在努力为病理和临床肿瘤学制定适合国家资源的指南。综上所述，这些努力表明，满足像洪都拉斯这样的低收入国家临床肿瘤学家需求的障碍虽然具有挑战性，但并非不可逾越。
